New cancer treatments are entering the market at an unrelenting, accelerated pace. Since 2018 alone, the FDA approved over 140 new cancer .. Read more indications, including 55 novel cancer drug entities. The explosive growth of treatment options in oncology means that the stakes for patients, providers, and health plans have never been higher. Health plans have small windows to carefully evaluate the appropriateness of new therapies and make needed course corrections.
- Share your Experience
More Events From The Organizer
- Utilization Management: Addres..20 - 21 Oct 2020Fort Lauderdale